home All News open_in_new Full Article

Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development

VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that Sabeen Mekan, M.D., has been appointed as Senior Vice President, Clinical Development. […]


today 25 h. ago attach_file Sport

attach_file Economics
attach_file Economics
attach_file Economics
attach_file Sport
attach_file Other
attach_file Other
attach_file Other
attach_file Sport
attach_file Other
attach_file Economics
attach_file Events
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Events
attach_file Events
attach_file Other
attach_file Economics
attach_file Other
attach_file Economics


ID: 3232166628
Add Watch Country

arrow_drop_down